API manufacturing finally getting the attention it deserves
While formulation generics flounders a bit, the data show that the Indian API industry has done better, with a five-year revenue…
Author
The biggest learning from the pandemic is around agility and robustness of the supply chain
Prabhat Verma, India Head, Integrated Supply Chain Operations (ISCO), Merck Life Science, gives details to Viveka Roychowdhury on…
Will FMRAI’s PIL finally prod govt to make UCPMP mandatory?
As COVID-19 continues to extract its price, will a more aware patient pool build up public opinion and turn the tide?
We do whatever we can to ensure safe use and administration of products
Dr Claus Runge, Global Head, Market Access, Public Affairs and Sustainability, Pharmaceuticals Division, Bayer AG, and Viveka…
High expectations from the draft Bill
The regulation of all retail channels as proposed by the draft Drugs, Medical Devices and Cosmetics Bill 2022 becomes even more…
India’s medicine watchdog under the scanner once again
Hopefully, this case will initiate as deep a clean up and introspection as the 2012 PCC report
No one can stop Indian pharma exports
Kamlesh Shah, President and Sandeep Modi, Joint Secretary, Federation of Pharmaceutical And Allied Products Merchant Exporters…
Preparing for surprise inspections
Will surprise site inspections be the end of a long wait? Or the start of another tunnel into noncompliance?
Taking India beyond ‘Pharmacy of the World’
A policy to incentivise pharma R&D is crucial as there are already signs that pharma R&D dives when revenues dip
Will a limited vaccine waiver limit future options?
As attempts to ring-fence markets and restrict access continue, will India and South Africa toe the WTO line?